Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 5 (2008), Issue 1 (January)

1. Functional outcome after language mapping for glioma resection.
   N Engl J Med, 358(1): 18-27. [Abstract] [Full-text]
2. Oncolytic measles virus strains in the treatment of gliomas.
   Expert Opin Biol Ther, 8(2): 213-20. [Abstract] [Full-text]
3. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
   Pediatr Blood Cancer, 50(3): 554-60. [Abstract] [Full-text]
4. Speech-language and hearing complaints of children and adolescents with brain tumors.
   Pediatr Blood Cancer, 50(3): 706-8. [Abstract] [Full-text]
5. Somatostatin receptor scintigraphy in surveillance of pediatric brain malignancies.
   Pediatr Blood Cancer, 50(3): 561-6. [Abstract] [Full-text]
6. A novel splice mutation in the TP53 gene associated with Leydig cell tumor and primitive neuroectodermal tumor.
   Pediatr Blood Cancer, 50(3): 701-3. [Abstract] [Full-text]
7. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
   Pediatr Blood Cancer, 50(3): 715-7. [Abstract] [Full-text]
8. Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
   Pediatr Blood Cancer, 50(3): 699-700. [Abstract] [Full-text]
9. Analysis of serum FSH bioactivity in a patient with an FSH-secreting pituitary microadenoma and multicystic ovaries: A case report.
   Hum Reprod, 23(2): 435-9. [Abstract] [Full-text]
10. Anti-apoptosis mechanisms in malignant gliomas.
    J Clin Oncol, 26(3): 493-500. [Abstract] [Full-text]
11. A case of unexpected difficult airway due to lingual tonsil hypertrophy.
    Acta Anaesthesiol Scand, 52(2): 310-2. [Abstract] [Full-text]
12. Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
    Mol Pharmacol, 73(2): 338-48. [Abstract] [Full-text]
13. Does hyperventilation improve operating condition during supratentorial craniotomy? A multicenter randomized crossover trial.
    Anesth Analg, 106(2): 585-94, table of contents. [Abstract] [Full-text]
14. Radiotherapy for pituitary adenomas.
    Endocrinol Metab Clin North Am, 37(1): 263-75, xi. [Abstract] [Full-text]
15. Rare sellar lesions.
    Endocrinol Metab Clin North Am, 37(1): 195-211, x. [Abstract] [Full-text]
16. Craniopharyngiomas.
    Endocrinol Metab Clin North Am, 37(1): 173-93, ix-x. [Abstract] [Full-text]
17. Nonfunctioning pituitary tumors and pituitary incidentalomas.
    Endocrinol Metab Clin North Am, 37(1): 151-71, xi. [Abstract] [Full-text]
18. Thyrotropinomas.
    Endocrinol Metab Clin North Am, 37(1): 123-34, viii-ix. [Abstract] [Full-text]
19. Hyperprolactinemia and prolactinomas.
    Endocrinol Metab Clin North Am, 37(1): 67-99, viii. [Abstract] [Full-text]
20. Treatment of pituitary tumors: a surgical perspective.
    Endocrinol Metab Clin North Am, 37(1): 51-66, viii. [Abstract] [Full-text]
21. Molecular and trophic mechanisms of tumorigenesis.
    Endocrinol Metab Clin North Am, 37(1): 23-50, vii. [Abstract] [Full-text]
22. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma.
    Int J Cancer, 122(6): 1207-13. [Abstract] [Full-text]
23. Inhibition of telomerase in the endothelial cells disrupts tumor angiogenesis in glioblastoma xenografts.
    Int J Cancer, 122(6): 1236-42. [Abstract] [Full-text]
24. MGMT in primary and recurrent human glioblastomas after radiation and chemotherapy and comparison with p53 status and clinical outcome.
    Int J Cancer, 122(6): 1391-9. [Abstract] [Full-text]
25. Closing the survival gap: implementation of medulloblastoma protocols in a low-income country through a twinning program.
    Int J Cancer, 122(6): 1203-6. [Abstract] [Full-text]
26. Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
    PLoS Med, 5(1): e8. [Abstract] [Full-text]

© 2004-2008 Brain Cancer Research Today. All Rights Reserved.